Is it virtuous to be virtual? the VC viewpoint

Nature Biotechnology

Volumn 27, Issue 10, 2009, Pages 886-888

  Chakma, Justin ^a   Calcagno, Jeff L ^b   Behbahani, Ali ^c   Mojtahedian, Shawn ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Scale Venture Partners   (United States)

^c New Enterprise Associates   (United States)

^d Innovative Neurotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CAPITAL; COMMERCIAL PHENOMENA; DRUG DEVELOPMENT; DRUG INDUSTRY; LETTER; PATENT; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW;

BIOTECHNOLOGY; HUMANS; INDUSTRY; INVESTMENTS; OUTSOURCED SERVICES;

EID: 70349941112     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1009-886     Document Type: Letter

References (4)

1. Booth B.L. Nat. Biotechnol. 27 705-709 2009
2. Booth, B. Nat. Biotechnol. 25, 853-857 (2007).
3. Klausner A. Nat. Biotechnol. 27, 125-127 (2009).
4. Christenson, C. et al. The Innovator?s Prescription: A Disruptive Solution for Health Care (McGraw-Hill, New York, 2009).